The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,188.00
Bid: 4,185.00
Ask: 4,187.00
Change: 8.00 (0.19%)
Spread: 2.00 (0.048%)
Open: 4,164.00
High: 4,188.00
Low: 4,163.00
Prev. Close: 4,180.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

29 Apr 2020 15:52

RNS Number : 3748L
Unilever PLC
29 April 2020
 

UNILEVER PLC

 

ANNUAL GENERAL MEETING

 

ALL RESOLUTIONS APPROVED

 

 

Unilever PLC shareholders today approved all resolutions put to the 2020 Annual General Meeting. Voting was by poll on each resolution and the results are set out below.

 

 

BOARD APPOINTMENTS

 

The following directors stood for re-election and were duly re-elected by the shareholders of Unilever PLC:

Nils Andersen, Laura Cha, Vittorio Colao, Judith Hartmann, Alan Jope, Andrea Jung, Susan Kilsby, Strive Masiyiwa, Youngme Moon, Graeme Pitkethly, John Rishton and Feike Sijbesma.

 

Marijn Dekkers will retire as a Non-Executive Director at the close of the Unilever N.V. AGM on 30 April 2020.

 

POLL RESULTS - ANNUAL GENERAL MEETING 29 APRIL 2020

 

 

TOTAL VOTES FOR

%

TOTAL VOTES AGAINST

%

TOTAL VOTES CAST

% OF SHARE CAPITAL VALIDLY CAST VOTED FOR AND AGAINST

VOTES WITHHELD

1.

To receive the Report and Accounts for the year ended 31 December 2019

882,934,344

99.75

2,171,568

0.25

885,105,912

75.75%

880,468

2.

To approve the Directors' Remuneration Report

833,921,248

95.51

39,227,970

4.49

873,149,218

74.72%

12,833,255

3.

To re-elect Mr N Andersen as a Director

859,927,272

97.89

18,579,693

2.11

878,506,965

75.18%

7,476,315

4.

To re-elect Mrs L Cha as a Director

883,816,044

99.82

1,604,016

0.18

885,420,060

75.77%

566,664

5.

To re-elect Mr V Colao as a Director

869,342,994

98.19

16,038,656

1.81

885,381,650

75.77%

605,074

6.

To re-elect Dr J Hartmann as a Director

845,437,246

96.01

35,134,063

3.99

880,571,309

75.36%

5,415,414

7.

To re-elect Mr A Jope as a Director

884,343,427

99.92

700,141

0.08

885,043,568

75.74%

932,632

8.

To re-elect Ms A Jung as a Director

866,572,845

97.91

18,459,496

2.09

885,032,341

75.74%

954,383

9.

To re-elect Ms S Kilsby as a Director

882,196,487

99.64

3,217,932

0.36

885,414,419

75.77%

572,305

10.

To re-elect Mr S Masiyiwa as a Director

884,487,385

99.90

885,538

0.10

885,372,923

75.77%

613,801

11.

To re-elect Professor Y Moon as a Director

884,364,266

99.88

1,024,335

0.12

885,388,601

75.77%

596,123

12.

To re-elect Mr G Pitkethly as a Director

877,437,680

99.10

7,931,475

0.90

885,369,155

75.77%

615,569

13.

To re-elect Mr J Rishton as a Director

879,757,072

99.37

5,595,463

0.63

885,352,535

75.77%

632,189

14.

To re-elect Mr F Sijbesma as a Director

882,431,804

99.67

2,913,908

0.33

885,345,712

75.77%

633,555

15.

To reappoint KPMG LLP as Auditors of the Company

880,177,942

99.93

643,801

0.07

880,821,743

75.38%

5,162,981

16.

To authorise the Directors to fix the remuneration of the Auditor

879,446,646

99.33

5,924,244

0.67

885,370,890

75.77%

611,350

17.

To authorise Political Donations and Expenditure

859,159,366

97.06

26,011,156

2.94

885,170,522

75.75%

804,577

18.

To renew the authority to Directors to issue shares

869,530,499

98.22

15,780,479

1.78

885,310,978

75.76%

673,054

19.

To renew the authority to Directors to disapply pre-emption rights

882,317,117

99.68

2,852,116

0.32

885,169,233

75.75%

817,490

20.

To renew the authority to Directors to disapply pre-emption rights for the purposes of acquisitions or capital investments

876,179,553

98.97

9,076,664

1.03

885,256,217

75.76%

730,180

21.

To renew the authority to the Company to purchase its own shares

874,752,481

98.84

10,297,470

1.16

885,049,951

75.74%

936,366

22.

To shorten the Notice period for General Meetings

829,246,316

93.67

56,059,572

6.33

885,305,888

75.76%

679,914

 

 

NOTES:

- The 'For' vote includes votes given at the Chairman's discretion and details of proxy votes cast are included to in the table above.

- The total number of Unilever PLC Ordinary shares with voting rights in issue at 2.30pm on Wednesday 29 April 2020 was 1,168,530,650. Unilever PLC does not hold any shares in treasury.

 

A 'Vote withheld' is not a vote in law and will not be counted in the calculation of the proportion of the votes 'for' and 'against' a resolution.

 

In accordance with Listing Rule 9.6.2 copies of all the resolutions passed, other than ordinary business, will be submitted to and available for inspection at the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. A copy of the resolutions can also be found in the Chairman's Letter and Notice of Meeting which is available on our website: www.unilever.com/AGM

 

 

 

29 April 2020

 

 

 

Safe Harbour:

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current COVID-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2019 and the Unilever Annual Report and Accounts 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGZKLFLBZLZBBQ
Date   Source Headline
1st May 20244:10 pmRNSResult of AGM
1st May 20243:17 pmRNSCommittee Composition
1st May 20249:06 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSQ1 2024 Trading Statement
2nd Apr 20243:58 pmRNSTotal Voting Rights
28th Mar 20245:04 pmRNSDirector/PDMR Shareholding
27th Mar 202412:32 pmRNSDirector/PDMR Shareholding
26th Mar 20246:13 pmRNSDirector/PDMR Shareholding
26th Mar 202411:58 amRNSDirector/PDMR Shareholding
25th Mar 20243:10 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSUnilever to accelerate Growth Action Plan
18th Mar 20243:00 pmRNSNotice of AGM
14th Mar 20242:14 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSBlock Listing of Shares
11th Mar 20245:55 pmRNSDirector/PDMR Shareholding
1st Mar 20242:36 pmRNSTotal Voting Rights
19th Feb 20243:14 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
1st Feb 20245:04 pmRNSTotal Voting Rights
31st Jan 20243:00 pmRNSDirectorate Change
16th Jan 20245:10 pmRNSBlock listing Interim Review
2nd Jan 20242:54 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20235:48 pmRNSDirector/PDMR Shareholding
12th Dec 20235:51 pmRNSDirector/PDMR Shareholding
11th Dec 20235:48 pmRNSDirector/PDMR Shareholding
11th Dec 20235:43 pmRNSDirector/PDMR Shareholding
4th Dec 20235:28 pmRNSTotal Voting Rights
23rd Nov 20233:51 pmRNSDirector/PDMR Shareholding
22nd Nov 20235:44 pmRNSDirector/PDMR Shareholding
10th Nov 20235:33 pmRNSDirector/PDMR Shareholding
8th Nov 20236:05 pmRNSDirector/PDMR Shareholding
1st Nov 20233:36 pmRNSTotal Voting Rights
30th Oct 20234:33 pmRNSStatement re Director Remuneration Report AGM Vote
26th Oct 20237:01 amRNSUnilever Announces New CFO
26th Oct 20237:00 amRNS3rd Quarter Results
18th Oct 20232:00 pmRNSCompletion of the 4th Tranche Share Buyback
17th Oct 20235:57 pmRNSTransaction in Own Shares
16th Oct 20236:01 pmRNSTransaction in Own Shares
13th Oct 20235:58 pmRNSTransaction in Own Shares
12th Oct 20235:50 pmRNSTransaction in Own Shares
12th Oct 20239:04 amRNSChanges to Membership of Board Committees
11th Oct 20236:06 pmRNSTransaction in Own Shares
11th Oct 20234:37 pmRNSDirector/PDMR Shareholding
10th Oct 20235:42 pmRNSTransaction in Own Shares
9th Oct 20236:05 pmRNSTransaction in Own Shares
6th Oct 20235:55 pmRNSTransaction in Own Shares
5th Oct 20235:46 pmRNSTransaction in Own Shares
4th Oct 20235:54 pmRNSTransaction in Own Shares
3rd Oct 20235:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.